Cardiovascular Pharmacology

Citations 71-80 of 92 total displayed.

Past content (since Jan 1999):

Thrombosis
HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells

Todd Bourcier and Peter Libby
Arterioscler Thromb Vasc Biol 2000;20:556-562 [Abstract] [Full text]  

Vascular Biology
Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation

Andreas H. Wagner, Thomas Köhler, Uwe Rückschloss, Ingo Just, and Markus Hecker
Arterioscler Thromb Vasc Biol 2000;20:61-69 [Abstract] [Full text]  

Atherosclerosis and Lipoproteins
Action of Atorvastatin in Combined Hyperlipidemia : Preferential Reduction of Cholesteryl Ester Transfer From HDL to VLDL1 Particles

Maryse Guerin, Taous S. Lassel, Wilfried Le Goff, Michel Farnier, and M. John Chapman
Arterioscler Thromb Vasc Biol 2000;20:189-197 [Abstract] [Full text]  

Brief Reviews
Platelet Glycoprotein IIb/IIIa Inhibitors : Basic and Clinical Aspects

Alan T. Nurden, Christel Poujol, Catherine Durrieu-Jais, and Paquita Nurden
Arterioscler Thromb Vasc Biol 1999;19:2835-2840 [Full text]  

Vascular Biology
Simvastatin Inhibits Leukocyte–Endothelial Cell Interactions and Protects Against Inflammatory Processes in Normocholesterolemic Rats

Diethard Pruefer, Rosario Scalia, and Allan M. Lefer
Arterioscler Thromb Vasc Biol 1999;19:2894-2900 [Abstract] [Full text]  

Atherosclerosis and Lipoproteins
Enhanced Reduction of Fasting Total Homocysteine Levels With Supraphysiological Versus Standard Multivitamin Dose Folic Acid Supplementation in Renal Transplant Recipients

Andrew J. Beaulieu, Reginald Y. Gohh, Haewook Han, David Hakas, Paul F. Jacques, Jacob Selhub, and Andrew G. Bostom
Arterioscler Thromb Vasc Biol 1999;19:2918-2921 [Abstract] [Full text]  

Atherosclerosis and Lipoproteins
Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women : A 2-Year, Placebo-Controlled Study

Gerdien W. de Valk-de Roo, Coen D.A. Stehouwer, Piet Meijer, Velja Mijatovic, Cornelis Kluft, Peter Kenemans, Fredric Cohen, Steven Watts, and Coen Netelenbos
Arterioscler Thromb Vasc Biol 1999;19:2993-3000 [Abstract] [Full text]  

Thrombosis
Intravenous and Oral Antithrombotic Efficacy of the Novel Platelet GPIIb/IIIa Antagonist Roxifiban (DMP754) and Its Free Acid Form, XV459

Shaker A. Mousa, Ram Kapil, and Dun-Xu Mu
Arterioscler Thromb Vasc Biol 1999;19:2535-2541 [Abstract] [Full text]  

Thrombosis
Antithrombotic Efficacy of the Vitamin K Antagonist Fluindione in a Human Ex Vivo Model of Arterial Thrombosis : Effect of Anticoagulation Level and Combination Therapy With Aspirin

Jean-Pierre Bossavy, Kjell S. Sakariassen, Claire Thalamas, Bernard Boneu, and Yves Cadroy
Arterioscler Thromb Vasc Biol 1999;19:2269-2275 [Abstract] [Full text]  

Thrombosis
Specific Impairment of Human Platelet P2Y_AC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel

J. Geiger, J. Brich, P. Hönig-Liedl, M. Eigenthaler, P. Schanzenbächer, J. M. Herbert, and U. Walter
Arterioscler Thromb Vasc Biol 1999;19:2007-2011 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10